• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular Myoplasty for Ischemic Heart Disease

Research Project

Project/Area Number 09670755
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionTEIKYO UNIVERSITY

Principal Investigator

TAKESHITA Satoshi  TEIKYO UNIVERSITY SCHOOL OF MEDlCINE DEPARTMENT OF MEDICINE Instructor, 医学部, 講師 (90271288)

Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 1998: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1997: ¥2,400,000 (Direct Cost: ¥2,400,000)
Keywordsgene therapy / myocardial ischemia / angiogenesis / angrogenesis / 遺伝子治療 / 心筋梗塞 / ラット
Research Abstract

Background Recent investigations have demonstrated the ability of vascular endothelial growth factor (VEGF) to augment the development of collateral arteries in vivo. in vitro studies have suggested that the use of VEGF also improves the endothelium-dependent relaxation of collaterals at the microvascular level. The purpose of this study was to determine in vivo the extent to which vasomotor responses of collateral microvessels are altered following VGEF-treatment
Methods and Results Ischemia was indiced in the hinclimb of 35 rats by excision of the femoral artery. Immediately thereafter, 400 mug of a plasmid encoding VEGF or beta-galactosidase (control) was transfected into limb muscles. Four weeks later, synchrotron radation microangiography, with a spatial resolution of 30 mum, was performed to document the reactivity of collateral microvessels. Administration of the endothelium-dependent vasodilator acetylcholine failed to induce dilation of collateral microvessels in control animals. By contrast, profound dlation of collaterals was observed after acetylcholine in VEGF-treated animals. This response was evident in vessels with a linear appearance but not in those with an undulating appearance. The resulting blood flow in the ischemic limb after administration of acetylcholine in the control animals was only 64.6*17.0% of that of the contralateral normal limb, whereas blood flow was augmented to 106.11*8.4% in VEGF-treated animals (P<.05).
Conclusions These results demonstrate in vivo that the use of VEL3F restores impaired vasomotor responses in some types of collateral microvessels, which may help to provide a basis for understanding the microcirculation following therapeutic angiogenesis with VEGE.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] Satoshi Takeshita: "Endo the lium-dependent relaxation of collateral microvessels after intra-muscmlar gene transfer of vascular crtlothelial growth factor in a rat model of hindlimb ischemia" circulation. 98. 1261-1263 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Satoshi Takeshita, et al.: "Endothelium-Dependent Relaxation of Collateral Microvessels Following Intramuscular Gene Transfer of Vascular Endothelial Growth Factor in a Rat Model of Hindlimb Ischemia" Circulation. 98. 1261-1263 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Satoshi Takeshita: "Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischeinia" Circulation. 98. 1261-1263 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi